Fig. 1From: An observational study in an urban Ugandan clinic comparing virological outcomes of patients switched from first-line antiretroviral regimens to second-line regimens containing ritonavir-boosted atazanavir or ritonavir-boosted lopinavirFollow up status of patients ever started on boosted atazanavir and on boosted lopinavir at time of studyBack to article page